Arcutis Biotherapeutics, Inc. (ARQT) has 136 open-market insider trades by 23 insiders since 2020. Over the last six months insiders net sold $1.7M. The most active filer is Howard G. Welgus, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Orbimed Capital LLC | 10% Owner | — | 1 | $25.4M | 2022-04-08 |
| Jonathan Silverstein | Dir10% Owner | — | 2 | $21.9M | 2020-10-02 |
| OrbiMed Capital GP VII LLC | 10% Owner | — | 1 | $14.6M | 2022-06-24 |
| Patrick J. Heron | Dir | — | 8 | $9.1M | 2026-06-05 |
| FHM LIFE Sciences Viii, L.P. | Dir10% Owner | — | 1 | $5.0M | 2022-08-05 |
| Adam Koppel | 10% Owner | — | 1 | $5.0M | 2020-02-04 |
| Patrick Burnett | — | — | 21 | $4.4M | 2026-08-19 |
| Todd Franklin Watanabe | — | — | 18 | $2.4M | 2025-06-10 |
| Howard G. Welgus | Dir | — | 24 | $2.4M | 2026-09-15 |
| Todd Watanabe | — | — | 6 | $2.1M | 2026-08-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Masaru Matsuda | — | Sell | $92K | 2026-09-16 |
| Howard G. Welgus | Director | Sell | $114K | 2026-09-15 |
| Masaru Matsuda | — | Sell | $250K | 2026-09-08 |
| Terrie Curran | Director | Sell | $956K | 2026-08-27 |
| Terrie Curran | Director | Sell | $28K | 2026-08-20 |
| Patrick Burnett | — | Sell | $46K | 2026-08-19 |
Companies that share insiders with ARQT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Howard G. Welgus | Director | Sell | $124K | 2026-08-17 |
| Patrick Burnett | — | Sell | $395K | 2026-08-11 |
| Patrick Burnett | — | Sell | $25K | 2026-08-03 |
| Todd Watanabe | — | Sell | $114K | 2026-08-03 |
| Masaru Matsuda | — | Sell | $32K | 2026-08-03 |
| Howard G. Welgus | Director | Sell | $127K | 2026-07-15 |
| Howard G. Welgus | Director | Sell | $116K | 2026-06-15 |
| Sue-jean Lin | Director | Sell | $121K | 2026-06-15 |
| Patrick Burnett | — | Sell | $5K | 2026-05-11 |